
enVVeno Medical Corporation
NASDAQ:NVNO
3.63 (USD) • At close May 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | |||||||||||
Net Income
| -21.819 | -23.516 | -24.669 | -16.528 | -9.135 | -7.625 | -13.043 | -7.791 | -3.387 | -1.604 | -0.001 |
Depreciation & Amortization
| 0.528 | 0.546 | 0.525 | 0.453 | 0.384 | 0.397 | 0.133 | 0.139 | 0.151 | 0.125 | 0 |
Deferred Income Tax
| 0 | 0 | 0 | -0.313 | -0.184 | 0.589 | -1.353 | -0.231 | 0.871 | 0 | 0 |
Stock Based Compensation
| 4.141 | 5.196 | 8.994 | 5.999 | 0.881 | 0.942 | 1.922 | 0.878 | 1.51 | 0 | 0 |
Change In Working Capital
| 0.29 | -0.616 | -0.13 | -1.145 | 0.666 | 0.067 | -0.578 | 1.093 | 0.269 | -0.541 | 0 |
Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0.032 | 0.003 | -0.012 | 0.309 | 0.025 | -0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | -0.217 | 0.091 | -0.213 | 0.172 | -0 |
Accounts Payables
| 0 | -0.221 | 0.088 | -0.833 | 0.169 | 0.144 | -0.294 | 0.545 | -0.076 | -0.084 | 0 |
Other Working Capital
| 0.29 | -0.395 | -0.218 | -0.312 | 0.497 | -0.109 | -0.07 | 0.468 | 0.25 | -0.654 | 0 |
Other Non Cash Items
| 0.022 | -0.468 | -0.339 | -0.313 | -0.289 | -0.265 | 6.563 | 1.71 | -2.499 | -0 | 0.001 |
Operating Cash Flow
| -16.838 | -18.858 | -15.619 | -11.846 | -7.677 | -5.896 | -6.356 | -4.202 | -3.085 | -2.019 | 0 |
Investing Activities: | |||||||||||
Investments In Property Plant And Equipment
| -0.037 | -0.033 | -0.115 | -0.368 | -0.18 | -0.364 | -0.012 | -0.011 | -0.374 | -0.003 | -0 |
Acquisitions Net
| 0 | 0 | 0.034 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Purchases Of Investments
| -55.567 | -56.52 | -48.127 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 56.939 | 48.685 | 13.688 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Investing Activites
| 0 | 0 | -0.034 | 0 | 0 | 0 | 0 | 0.176 | -0.332 | -0.075 | 0 |
Investing Cash Flow
| 1.335 | -7.868 | -34.554 | -0.368 | -0.18 | -0.364 | -0.012 | 0.165 | -0.705 | -0.078 | -0 |
Financing Activities: | |||||||||||
Debt Repayment
| 0 | 0 | 0 | 0 | 0.313 | 0 | 2.08 | 2.976 | 0.001 | 0.699 | 0 |
Common Stock Issued
| 13.591 | 25.791 | 0 | 57.362 | 10.418 | 5.637 | 7.657 | 1.082 | 0 | 1.871 | 0 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 0.046 | 0 | 0 | 0.245 | 16.12 | 0 | -0.707 | 1.082 | 2.949 | 2.926 | -0.06 |
Financing Cash Flow
| 13.637 | 25.791 | 0 | 57.607 | 15.075 | 5.637 | 9.031 | 4.058 | 2.261 | 3.624 | -0 |
Other Information: | |||||||||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net Change In Cash
| -1.866 | -0.935 | -50.173 | 45.393 | 7.217 | -0.623 | 2.663 | 0.021 | -1.529 | 1.527 | 0 |
Cash At End Of Period
| 1.754 | 3.62 | 4.555 | 54.728 | 9.335 | 2.117 | 2.741 | 0.078 | 0.057 | 1.585 | 0 |